REPL
REPL
NASDAQ · Biotechnology

Replimune Group Inc

$17.61
+0.22 (+1.27%)
REPL vs Biotechnology Average
Profit Margin
REPL -28.5%
Avg -192.1%
Rev Growth
REPL -3.7%
Avg +12.8%

Biotechnology Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
REPL Replimune Group Inc $17.61 +1.27% 1.65B — -28.5% -3.7% — Current
ABBV Abbvie Inc $288.24 -2.24% 513.86B 81.4 6.9% +1.8% 4.47% Strong buy Compare
AMGN Amgen Inc $460.28 -3.80% 249.09B 28.5 21.0% +11.8% 3.21% Hold Compare
GILD Gilead Sciences Inc $167.57 -3.96% 212.04B — 28.9% +2.6% 3.98% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $542.50 -1.19% 134.77B 30.6 32.9% +10.4% — Strong buy Compare
MRNA Moderna Inc $241.46 -6.55% 87.83B — -145.2% -53.4% — Hold Compare
REGN Regeneron Pharmaceuticals $902.90 -2.98% 84.30B 19.5 31.4% +5.6% — Buy Compare
NTRA Natera Inc $363.76 -6.97% 59.42B — -9.0% +41.1% — Strong buy Compare
RVMD Revolution Medicines Inc $177.65 -11.04% 40.97B — 4.4% +0.4% — Strong buy Compare
BIIB Biogen Inc $243.93 -4.14% 37.50B 44.9 13.1% -0.9% — Buy Compare
ROIV Roivant Sciences Ltd $36.62 -4.21% 26.66B — -3,629.2% -48.7% — Strong buy Compare
UTHR United Therapeutics Corp $565.72 -7.03% 25.46B 19.4 41.9% +18.0% — Strong buy Compare
INSM Insmed Inc $108.76 -1.13% 24.55B — -210.5% +35.2% — Strong buy Compare
INCY Incyte Corp $118.01 -3.94% 24.54B 15.2 25.0% +14.8% — Hold Compare
ALNY Alnylam Pharmaceuticals Inc $156.66 -2.74% 23.28B 28.8 8.5% +53.0% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
EXEL Exelixis Inc $68.71 -5.55% 17.68B 20.5 33.7% +12.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $159.76 -3.79% 14.93B 21.2 16.7% +24.3% — Strong buy Compare
HALO Halozyme Therapeutics Inc $122.96 -5.66% 14.89B 36.0 22.7% +28.4% — Strong buy Compare
BBIO Bridgebio Pharma Inc $74.27 -4.65% 14.64B — -144.4% +86.3% — Strong buy Compare
SMMT Summit Therapeutics Inc $14.19 -12.24% 12.66B — 15.4% -3.6% — Buy Compare